ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,317,348 | -16.4% | 1,581,493 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $20,723,274 | -16.7% | 1,565,202 | -14.3% | 0.00% | 0.0% |
| Q1 2023 | $24,870,792 | -63.3% | 1,827,391 | -47.4% | 0.00% | -50.0% |
| Q4 2022 | $67,858,548 | +69.0% | 3,474,580 | +64.8% | 0.00% | -33.3% |
| Q3 2022 | $40,155,000 | -21.3% | 2,107,868 | -14.9% | 0.00% | 0.0% |
| Q2 2022 | $51,054,000 | -7.3% | 2,478,332 | +44.8% | 0.00% | 0.0% |
| Q1 2022 | $55,089,000 | +55.0% | 1,711,891 | +124.3% | 0.00% | +50.0% |
| Q4 2021 | $35,542,000 | +308.7% | 763,351 | +137.0% | 0.00% | – |
| Q3 2021 | $8,697,000 | +6.6% | 322,107 | +1.2% | 0.00% | – |
| Q2 2021 | $8,161,000 | -66.0% | 318,169 | -54.7% | 0.00% | -100.0% |
| Q1 2021 | $24,029,000 | +275.9% | 703,010 | +272.0% | 0.00% | – |
| Q4 2020 | $6,392,000 | +97.5% | 189,002 | +44.0% | 0.00% | – |
| Q3 2020 | $3,237,000 | – | 131,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |